Crimson Life Sciences Solves Japanese Translation Dilemma for U.S. Medical Device Manufacturers

TOKYO--(BUSINESS WIRE)--Crimson Life Sciences, a division of TransPerfect and the world’s only ISO 13485 and ISO 14971-certified translation provider, today announced the opening of a dedicated production facility in Tokyo, Japan. Utilizing TransPerfect’s proprietary GlobalLink™ Translation and Review Portal, Crimson Japan provides a solution for manufacturers who are struggling with translation issues in the challenging Japanese market.